About the journal
Cancer Research is a journal published by American Association for Cancer Research in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- American Association for Cancer Research
- ISSN
- 0008-5472 · 1538-7445
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://cancerres.aacrjournals.org/
Index listings
- MEDLINE · 1965-01-01
- PUBMED · 1987-01-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 218 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
159192
Last recorded publication year
2026
h-index
467
i10-index
18642
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 4%
- ORCID iDs in current deposits
- 4%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 2984705R
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Research and Treatments
- Cancer Research and Treatments
Show all subjects (50)
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- CAR-T cell therapy research
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Nanoplatforms for cancer theranostics
- Nanoplatforms for cancer theranostics
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Molecular Biology Techniques and Applications
- Molecular Biology Techniques and Applications
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ